Aryl Urea Based Scaffolds for Multitarget Drug Discovery in Anticancer Immunotherapies
Twenty-one styryl and phenethyl aryl ureas have been synthetized and biologically evaluated as multitarget inhibitors of Vascular endothelial growth factor receptor-2 VEGFR-2 and programmed death-ligand-1 (PD-L1) proteins in order to overcome resistance phenomena offered by cancer. The antiprolifera...
Saved in:
Main Authors: | Celia Martín-Beltrán (Author), Raquel Gil-Edo (Author), Germán Hernández-Ribelles (Author), Raül Agut (Author), Pilar Marí-Mezquita (Author), Miguel Carda (Author), Eva Falomir (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling the Potential of BenzylethyleneAryl-Urea Scaffolds for the Design of New Onco Immunomodulating Agents
by: Raquel Gil-Edo, et al.
Published: (2023) -
Multitarget Pharmacology of Sulfur-Nitrogen Heterocycles: Anticancer and Antioxidant Perspectives
by: Aliki Drakontaeidi, et al.
Published: (2024) -
Drug discovery and computational strategies in the multitarget drugs era
by: Jéssika de Oliveira Viana, et al.
Published: (2018) -
Anticancer Activity of 4-Aryl-1,4-Dihydropyridines
by: Thaís A. S. Oliveira, et al.
Published: (2024) -
Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1H-pyrazole derivatives as a novel selective inhibitor scaffold of JNK3
by: Youri Oh, et al.
Published: (2020)